\
&
Contact us
\
&
Contact us
Published on | 3 months ago
Programmes Digital, Industry & Space EIC EDFThere are 2 attachments connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
We are happy to share that the pre-release version of the ISOS Pilot Mission Guidance Document has just been published on the DEFIS Website (bottom of the page).
This document, prepared in tight coordination with the Pilot Mission Advisory Group (PMAG) composed of Member States/EEA countries, will soon be complemented by the Mission High-Level Requirements. The full version will be uploaded to the Funding and Tenders portal and will guide applicants for the forthcoming Horizon Europe Cluster 4 ISOS calls, and also inform other programmes (EDF and EIC).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
